Validation of a Predictive Rule for the Diagnosis of Viral Meningitis in Adult Emergency Departments

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT05062642

Acronym

Adult-BMS

Enrollment

1000

Registered

2021-09-30

Start date

2021-08-26

Completion date

2022-08-26

Last updated

2022-01-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Meningitis

Keywords

BMS score, Meningitis

Brief summary

Meningitis is the development of an inflammatory reaction in the meningeal space, most often of infectious origin. Many pathogens can cause meningitis, the severity of which varies greatly. Patients presenting with a febrile meningeal syndrome are most often managed in the emergency room, where the challenge for physicians is to quickly differentiate bacterial and viral meningitis. Viral meningitis is the most common, with enterovirus meningitis having a classically excellent prognosis. Bacterial meningitis is less frequent but more serious.The current public health objective is to save antibiotics. Investigator hypothesizes that the BMS score can be used to exclude bacterial meningitis in the emergency department in an adult European population of patients with suspected bacterial meningitis.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Patient admitted to the Adult Emergency Department of CH Le Mans,CHU Angers, CHU Nantes or Beaujon Hospital. * Over 18 years old * Having had a lumbar puncture during their stay in the Adult Emergency Department * Having had a diagnosis of meningitis defined as a pleocytosis ≥ 5leukocytes/mm3 after correction with CSF red blood cells at a standardized ratio of 500/1.

Exclusion criteria

* Antibiotic therapy within 72 hours of inclusion * Immunosuppression from any cause * Presence of petechiae or purpura * History of recent neurosurgery or head trauma * Other associated bacterial infection * Inability to collect information for the BMS score calculation or primary endpoint (e.g., transfer to another facility) * Minor or adult patient under guardianship or protection

Design outcomes

Primary

Measure	Time frame	Description
External validation of the BMS score in a European adult population to exclude bacterial meningitis	1 month after inclusion	Validation was measured by comparaison between BMS score and the diagnosis retained from the data collected in the file

Countries

France

Contacts

Primary ContactChristelle JADEAU

cjadeau@ch-lemans.fr02 44 71 07 81

Backup ContactJean-Christophe CALLAHAN, MD

jccallahan@ch-lemans.fr02 43 43 43 43

Outcome results